Manifesting the Dasatinib-gallic acid co-amorphous system to augment anticancer potential: Physicochemical characterization, in silico molecular simulation, ex vivo …
Dasatinib (DAB) has been explored for repurposing in the treatment of breast cancer (BC)
due to its known effectiveness in treating leukemia, in addition to its role as a tyrosine kinase …
due to its known effectiveness in treating leukemia, in addition to its role as a tyrosine kinase …
Investigating the effect of polyvinylpyrrolidone matrix on surface characteristics and dissolution rate of anticancer drug dasatinib
K Sokač, P Priselec, J Barač, A Bafti… - Journal of applied …, 2024 - Wiley Online Library
Dasatinib (DAS) is a second‐generation tyrosine kinase inhibitor used in the treatment of
Philadelphia chromosome‐positive chronic myeloid leukemia and acute lymphoblastic …
Philadelphia chromosome‐positive chronic myeloid leukemia and acute lymphoblastic …